Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

l product sales 1,106.9 889.3 24% 94% Royalties: ADDERALL XR 25.3 16.8 51% 2% 3TC and ZEFFIX 13.6 35.5 -62% 1% FOSRENOL 10.0 8.1 23% 1% Other 7.4 13.2 -44% <1% Total royalties 56.3 73.6 -24% 5% Other revenues 8.6 9.3 -8% 1% Total revenues 1,171.8 972.2 21% 100%

Unaudited results for the three months to March 31, 2012

Non GAAP reconciliation

3 months to March 31, 2012 US GAAP Adjustments Non GAAP (a) (b) (c) (d) $M $M $M $M $M $M Total revenues 1,171.8 - - - - 1,171.8 Costs and expenses: Cost of product sales 158.4 - - - (7.2) 151.2 R&D 220.3 - (23.0) - (6.4) 190.9 SG&A 500.0 (45.6) - (13.6) 440.8 Gain on sale of product rights (7.2) - - 7.2 - - Integration and acquisition costs 5.3 - (5.3) - - - Depreciation - - - - 27.2 27.2 Total operating expenses 876.8 (45.6) (28.3) 7.2 - 810.1 Operating income 295.0 45.6 28.3 (7.2) - 361.7 Interest income 0.8 - - - - 0.8 Interest expense (10.2) - - - - (10.2) Other income, net 1.9 - - - - 1.9 Total other expense, net (7.5) - - - - (7.5) Income before income taxes and equity in earnings of equity method investees 287.5 45.6 28.3 (7.2) - 354.2 Income taxes (50.0) (13.2) (6.6) - (69.8) Equity in earnings of equity method investees, net of tax 0.9 - - - - 0.9 Net income 238.4 32.4 21.7 (7.2) - 285.3 Impact of convertible debt, net of tax 8.4 - - - - 8.4 Numerator for diluted EPS 246.8 32.4 21.7 (7.2) - 293.7 Weighted average number of shares (millions) - diluted 595.6 - - - - 595.6 Diluted earnings per ADS 124.2c 16.3c 10.9c (3.5c) - 147.9c

The following items are included in Adjustments:

    (a) Amortization and asset impairments: Amortization of intangible assets relating to intellectual property rights acquired ($45.6 million), and tax effect of adjustments;

    (b) Acquisition and integration activities: Up-front payments made to Sangamo and for the acquisition of the US rights to prucalopride (markete
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Moerae Matrix, a clinical stage biotechnology ... inflammation and fibrosis, today announced the appointment of ... Medical Officer. Dr. Bradford will ... which include a pipeline of therapies for pulmonary ... is an accomplished strategist and scientist with extensive ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... --  Cepheid (Nasdaq: CPHD ) today announced that ... quarter ended June 30, 2015 on Thursday, July 23, ... The Company will host a management presentation at 2 ... discuss the results.  To access the live webcast, please ... 15 minutes before the scheduled start time to download ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... 2011 VolitionRX Limited ("Volition") (VNRX.OB), ... diagnostic tests, is pleased to announce that its ... signed a contract which is expected to provide ... commissioned to develop epigenetic profiling signatures from blood. ...
... Technology Services successfully implemented advanced process technology for ... in Shanghai, China, using Intergraph® integrated design and ... solvent and energy consumption as well as operating ... http://photos.prnewswire.com/prnh/20081211/DECLOGO) These results are achieved, among ...
Cached Medicine Technology:VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures 2VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures 3Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China 2Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China 3
(Date:7/6/2015)... Florida (PRWEB) , ... July 06, 2015 , ... MD ... on Monday, July 6. The newly constructed urgent care center will serve residents and ... , In addition to being MD Now’s 22nd South Florida location, the new facility ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School ... funds to support a three-year effort to reduce rates of diabetes and cardiovascular ... in partnership with the Morehouse School of Medicine’s Prevention Research Center and the ...
(Date:7/6/2015)... ... 06, 2015 , ... Promero, a leading cloud hosting provider ... IP contact center solution hosted by Promero. Randstad Technologies,a leading talent and ... call center platform. , Promero will implement and manage the private cloud ...
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and a ... received the Music & Memory Certification for hospice patients and adult day center participants. ... not only to patients but also to their families and volunteers. Music & Memory ...
(Date:7/5/2015)... ... 06, 2015 , ... City Sports, the Boston-based specialty sporting goods retailer, has ... for first-time triathletes this summer with ethos, the owner and operator of the Boston ... at 6:00 p.m. at the North End Greenway. The event will help new triathletes ...
Breaking Medicine News(10 mins):Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3
... Technologies(R),Inc. (OTC Bulletin Board: GLOB), an international ... its Wyndgate,Technologies(R) ("Wyndgate"), division will be a ... Transfusion Medicine Expo (TXPO). (Logo: ... 1947, is a leader in the development ...
... for smokers, experts say , THURSDAY, Oct. 11 (HealthDay News) ... that could give doctors early warning of lung cancer. , ... 104 people with different types of lung cancer and 50 ... autoantibodies -- immune system proteins that are directed at the ...
... Oridion,Systems, Ltd. - (SWX: ORIDN) introduces ... patient safety. This new launch takes ... in San Francisco, CA. Smart Capnography ... new SARA(TM) software for improved alarm management.,Microstream ...
... ... cold medicines for children age ... 2 and older,- Further evaluation of these oral ... 19 FDA advisory committee meeting, WASHINGTON, Oct. 11 The Consumer Healthcare Products,Association ...
... no longer afford to,ignore the growing obesity epidemic. ... on obesity-attributable health care(1). In addition, an,estimated 39 ... each,year(2). Other costs of obesity in the workplace ... Today, business leaders, healthcare industry professionals and,policymakers will ...
... concentrated Tylenol(R) Infants, Drops Plus Cold ... ... WASHINGTON, Pa., Oct. 11 McNeil Consumer,Healthcare, a division of McNeil-PPC, ... and cold products,from the market. When used as directed, these medicines ...
Cached Medicine News:Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 2Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 3Health News:Immune Proteins Warn of Early Lung Cancer 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 3Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 4Health News:Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines 2Health News:Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines 3Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 2Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 3Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 4Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 3
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Marlin' Cervical Orthosis ensures ... semirigid molded polyethylene anterior frame ... allows free air flow and ... facilitates height adjustment. For added ...
... Aspen® Cervical Collars improves patient compliance, ... costs. Adjusts to user's anatomy, wicks ... head weight to shoulders and upper ... Front and back airflow openings. Adjustable ...
... Designed with patient need and comfort ... Appliance) family of products effectively address ... The Chairback frame attachment provides optimal ... (LSO) provides superior support for patient ...
Medicine Products: